Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Positive interim data from controlled study of KB-109 in outpatients with COVID-19

Jan. 15, 2021

Alexion pauses enrollment in phase III study of Ultomiris for severe COVID-19

Jan. 14, 2021

'Unconventional' gamma-delta T cells recognize malaria-infected RBCs

Jan. 14, 2021

Synairgen initiates phase III study of inhaled interferon beta in hospitalized COVID-19 patients

Jan. 14, 2021

JD-1 preferentially targets cell membranes of Gram-negative bacteria

Jan. 13, 2021

U.S. researchers disclose compounds for West Nile viral infection

Jan. 13, 2021

M. tuberculosis-derived rRv-2626c-CA peptide protects mice from sepsis

Jan. 13, 2021

CureVac reports NHP data on COVID-19 vaccine candidate CVnCoV

Jan. 12, 2021

Leishmania parasites trigger SHP-1, which acts as a negative regulator of antigen cross-presentation

Jan. 12, 2021

DalCor initiates phase II study of dalcetrapib in patients with COVID-19

Jan. 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.